DICOM Viewer : eMma

0
DICOM Viewer : eMma
DICOM Viewer : eMma is an iOS app from 株式会社Kompath in the Education category, currently rated — across few ratings. Initial signal reads as no scraped reviews yet: judgment based on metadata only.
Quality Score is 0: Niche (micro-niche or pre-traction stage). For a Education app, that means micro-niche or pre-traction stage. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 📦 Asset bundle (91 MB) | +$16K |
| ⚙ Education complexity ×1.20 | +$13K |
How we forecast this revenue
LOW CONFIDENCEBU Investment Matrix
Pre-traction · 31/100INDIE TIERlimited signal- 💰 Revenue: Marginal — $200 - $1250/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: None★ across 0 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: ⚠ last update 2928d ago — possibly dormant.
- ⚠️ Risk: Moderate — dormant (2928d since update).
💰 Forecast Revenue / mo
MODEL| Mature app (8y old)METRIC | +$1,500 | |
| Ad-supported / freemiumMETRIC | +$600 | |
| Single-language (English only)METRIC | −$400 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVE🆕 What's New · v1.3
・DICOM読み込み速度の改善
・一部UIの変更
・不具合の修正
Profile & Insights
Identification
- App name
- DICOM Viewer : eMma
- Developer
- 株式会社Kompath
- Bundle ID
- Not found
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 12+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Today
- Description
- Find apps and games for iPhone, iPad, Mac, and more on the App Store.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $86/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
📝 About this app
MR、CT、SPECT、PET、X線、超音波などで撮影された医用画像(DICOM画像)を閲覧することができます。
医用画像はiTunes経由でご自身の端末に取り込みます。
取り込み後、本アプリを起動すると画像選択モードから始まり、詳しく見たい画像をタップすると閲覧モードに移行します。
【画像選択モード】
- 医用画像を高速に読み込み、複数の医用画像をすばやく同時に確認することができます。
- 患者名、撮影日、モダリティ、シーケンスごとに表示画像を切り替えることができます。
- 画像を上下にスライドすることでスライスの確認が出来ます。
- 閲覧したい医用画像をタップすると閲覧モードに移行します。
【閲覧モード】
- ウインドウレベルの調整、画像の拡大・平行移動がタッチ操作で簡単に行えます。
- CTやMR画像などは横断面(Axial)から再構成した冠状面(Coronal)、矢状面(Sagittal)画像を閲覧することができます。(3次元再構成)
- 2画面機能で画像間の比較ができます。
- シンクロ機能で2画面を同時に操作できます。
●Unite Tokyo 2018で紹介されました。
http://events.unity3d.jp/unitetokyo2018/session-lineup.html#session82… View full description on the official store →
What Worked™ · Development Pipeline
2 EVENTS TRACKEDMulti-Country Performance
Available in 9 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇦🇺 AU | 0★ | 0 | — |
| 🇧🇷 BR | 0★ | 0 | — |
| 🇨🇦 CA | 0★ | 0 | — |
| 🇩🇪 DE | 0★ | 0 | — |
| 🇫🇷 FR | 0★ | 0 | — |
| 🇬🇧 GB | 0★ | 0 | — |
| 🇮🇳 IN | 3★ | 1 | 3★ this version |
| 🇯🇵 JP | 4.03333★ | 30 | 4.03333★ this version |
| 🇺🇸 US | 1★ | 1 | 1★ this version |
Track this app’s revenue
FREE📝 Description
95
Why low confidence: only 0 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
DICOM Viewer : eMma is a very early-stage iOS app in the education space with weak public traction — only 0 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.




